Atlas Trials

The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical Trial

Clinical trial NCT03509688 · COMPLETED

Trial details

NCT number
NCT03509688
Sponsor
The First Hospital of Jilin University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatitis
Start date
2014-11-01
Primary completion
2017-12-01
Enrollment
312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.